• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非酒精性脂肪性肝病患者的心血管风险]

[Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease].

作者信息

Kim Hak Soo, Cho Yong Kyun

机构信息

Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Korean J Gastroenterol. 2017 Jun 25;69(6):333-340. doi: 10.4166/kjg.2017.69.6.333.

DOI:10.4166/kjg.2017.69.6.333
PMID:28637101
Abstract

Non-alcoholic fatty liver disease (NAFLD) includes a wide spectrum of diseases that range from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. In addition, the burden of NAFLD is rapidly growing. Previously, NAFLD was regarded as a hepatic manifestation of metabolic syndrome, which is a traditional cardiovascular disease (CVD) risk factor. However, there has been an increasing evidence that suggest NAFLD to be an independent risk factor of CVD. Therefore, currently, NAFLD should be reconsidered as not only a simple manifestation of metabolic syndrome, but also a systemic disease that contribute to CVD. There are some reasonable hypotheses about the relationship between NAFLD and CVD. Moreover, many studies have been performed to better understand this relationship. Nonetheless, the underlying mechanisms and pathogenesis of NAFLD that contribute to CVD have not yet been fully elucidated to date. This review focuses on the underlying mechanisms and relationship between NAFLD and CVD.

摘要

非酒精性脂肪性肝病(NAFLD)包括从单纯性脂肪变性到非酒精性脂肪性肝炎(NASH)和肝硬化等一系列广泛的疾病。此外,NAFLD的负担正在迅速增加。以前,NAFLD被视为代谢综合征的肝脏表现,而代谢综合征是传统的心血管疾病(CVD)危险因素。然而,越来越多的证据表明NAFLD是CVD的独立危险因素。因此,目前,NAFLD不仅应被重新视为代谢综合征的一种简单表现,还应被视为一种导致CVD的全身性疾病。关于NAFLD与CVD之间的关系有一些合理的假说。此外,已经进行了许多研究以更好地理解这种关系。尽管如此,迄今为止,导致CVD的NAFLD的潜在机制和发病机制尚未完全阐明。本综述重点关注NAFLD与CVD之间的潜在机制和关系。

相似文献

1
[Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease].[非酒精性脂肪性肝病患者的心血管风险]
Korean J Gastroenterol. 2017 Jun 25;69(6):333-340. doi: 10.4166/kjg.2017.69.6.333.
2
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现:最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
3
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.他汀类药物单独使用,或与吡格列酮及其他药物联合使用,用于治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎及相关心血管风险。专家小组声明。
Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4.
4
Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.他汀类药物:预防和治疗非酒精性脂肪性肝病或非酒精性脂肪性肝炎及相关心血管风险的被低估的资产。
Curr Vasc Pharmacol. 2018;16(3):246-253. doi: 10.2174/1570161115666170621082910.
5
Nonalcoholic fatty liver disease and cardiovascular disease.非酒精性脂肪性肝病与心血管疾病
Curr Pharm Des. 2014;20(14):2403-11. doi: 10.2174/13816128113199990476.
6
NAFLD and cardiovascular diseases: a clinical review.非酒精性脂肪性肝病与心血管疾病:临床综述。
Clin Res Cardiol. 2021 Jul;110(7):921-937. doi: 10.1007/s00392-020-01709-7. Epub 2020 Jul 21.
7
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.非酒精性脂肪性肝病作为心血管疾病的潜在危险因素。
Eur J Gastroenterol Hepatol. 2015 Mar;27(3):193-9. doi: 10.1097/MEG.0000000000000254.
8
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.非酒精性脂肪性肝病、胰岛素抵抗、代谢综合征及其与血管风险的关系。
Metabolism. 2021 Jun;119:154770. doi: 10.1016/j.metabol.2021.154770. Epub 2021 Apr 14.
9
Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的血管疾病。
Semin Thromb Hemost. 2015 Jul;41(5):488-93. doi: 10.1055/s-0035-1550433. Epub 2015 Jun 6.
10
Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.非酒精性脂肪性肝病及其与心血管病和其他肝外疾病的关系。
Gut. 2017 Jun;66(6):1138-1153. doi: 10.1136/gutjnl-2017-313884. Epub 2017 Mar 17.